Objective The incidence of sporadic inclusion body myositis (sIBM) in the Japanese population has increased, and some researchers have suggested that race and genetic background may influence the clinical features of the disease. The aim of this study was to clarify the demographic features of Japanese patients with sIBM. Methods We retrospectively evaluated the demographic features of consecutive patients who were referred to our institution between 1995 and 2011 for diagnostic muscle biopsies and who subsequently were diagnosed to have sIBM.
Introduction
Major inflammatory myopathies primarily include polymyositis (PM), dermatomyositis (DM) and sporadic inclusion body myositis (sIBM). These three inflammatory myopathies exhibit clinically distinct characteristics (1) . sIBM appears to be the most common age-associated mus- ground may influence the clinical features of this disease, few studies have confirmed this hypothesis (6) (7) (8) (9) . There are few reports of sIBM in Asian populations, including Japan. A recent study of Japanese patients with sIBM that examined a cohort of biopsy samples from the National Center of Neurology and Psychiatry revealed that the number of patients with sIBM is increasing in Japan (10) . Thus far, this has been the only report to propose that patient demographics are altering with time and to suggest that factors other than genetic background might play a role in the pathogenesis of sIBM. In this study, we verified the demographics of Japanese patients with sIBM using another cohort of patients.
Materials and Methods
We retrospectively reviewed consecutive patients who were referred to our institution for diagnostic muscle biopsies between 1995 and 2011 and received a diagnosis of a major inflammatory myopathy, namely PM, DM or sIBM. We enrolled patients with sIBM based on previously proposed criteria (3, (11) (12) (13) . The diagnoses of PM and DM were based on previously published criteria (14).
Muscle biopsies were performed in all patients, as previously described (15) (16) (17) . All specimens were obtained using open biopsies and were snap-frozen in isopentane, chilled in dry ice and preserved at -80 until further use. The samples were cut according to routine methods into 10-μm cryostat sections and stained with hematoxylin and eosin, modified Gomori trichrome, NADH-tetrazolium reductase, routine-ATPase, succinate dehydrogenase and cytochrome c oxidase.
Patient characteristics, including sex, age at onset and at diagnosis, initial symptoms of myopathy, activities of daily living and presence of dysphagia, were obtained retrospectively by reviewing the patients' medical records. Laboratory features determined at the time of diagnosis included the levels of serum creatine kinase (CK), immunoglobulin G, antinuclear autoantibodies, anti-Jo-1 antibodies, hepatitis B antigens and hepatitis C antibodies.
The functional status each patient was assessed according to the modified Rankin scale (mRS) based on the following criteria: 0: no symptoms; 1: no significant disabilities despite the presence of symptoms (able to carry out all usual duties and activities); 2: slight disability (unable to perform all activities previously performed but able to function sufficiently without assistance); 3: moderate disability (requiring some help but able to walk without assistance); 4: moderately severe disability (unable to walk or attend to one's own bodily needs without assistance); and 5: severe disability (bedridden, incontinent and requiring constant nursing care and attention) (18) .
This study conformed to the ethical guidelines for epidemiological studies endorsed by the Japanese Government. The Ethics Committee of the Nagoya University Graduate School of Medicine approved this study.
Quantitative data are presented as the mean ± SD. Statistical comparisons were performed using the χ 2 test or the Mann-Whitney U test, as appropriate. p values <0.05 were considered statistically significant. Table 3) .
The mean annual numbers of patients newly diagnosed with sIBM according to age at onset are shown in Figure. Compared with the patients diagnosed between 1995 and 2002 ( Figure A) , the number of newly diagnosed patients, especially those older than 60 years of age at disease onset, increased between 2003 and 2011 ( Figure B ). Since the size of the elderly population has been increasing in Japan, the annual number of patients diagnosed between 2003 and 2011 was adjusted for the relative increases in the sizes of the populations of each respective age range. In Aichi prefecture, the numbers of persons aged 30 to 39, 40 to 49, 50 to 59, 60 to 69 and 70 to 79 years were 1,061,161, 857,800, 1,068,227, 817,482 and 490,170, respectively, in 2002 and 1,119,601, 1,025,693, 850,657, 1,016,357 and 679,717, respectively, in 2011 (http://www.pref.aichi.jp/0000053149. html). (Our institute is located in Aichi prefecture, and 91% of our patients reside in Aichi prefecture.) After adjusting for the relative increases in the populations of each respective age range from 2002 to 2011, the annual numbers of patients diagnosed in each respective age range were found to be similar to those observed between 1995 and 2011 ( Figure C) .
The characteristics of the patients with sIBM are shown in Table 1 . The mean age at onset ranged from 43 to 78 years (63.9±7.9 years), the mean age at diagnosis ranged from 48 to 82 years (67.9±7.1 years) and the mean time course from onset to diagnosis ranged from 0.5 to 15.0 years (4.3±3.2 years). Four patients developed muscular symptoms before 50 years of age. In 67 patients, the initial symptom of myopathy was weakness in the lower limbs, primarily manifesting as difficulty in performing daily activities and climbing stairs due to weakness in the quadriceps femoris muscle. Four patients initially noted weakness in the upper extremities and two patients reported dysphasia as the first symptom. The mean mRS score at diagnosis was 2.8 (SD: 0.8; range: 2-4). The frequency of patients manifesting dysphagia and receiving a diagnosis within five years of onset was 20%, while 50% of the patients exhibited some difficulty in swallowing more than five years after onset.
The serum CK values ranged from 37 to 1,576 U/L (502± 350 U/L), and the immunoglobulin G levels ranged from 1,013 to 3,426 mg/dL (1,684±479 mg/dL). Test results for antinuclear antibodies were positive in 17 of 73 patients; however, no patient tested positive for Jo-1 antibodies. One patient was positive for hepatitis B virus antigens, and nine patients were positive for hepatitis C virus antibodies. These characteristics were not significantly different between the patients diagnosed before and including 2002 (n=29) and those diagnosed after 2002 (n=44). 2011 (shown in B) was adjusted for the relative increases in the populations of each respective age range (C). After adjustment, the annual number of patients diagnosed in each respective age range was found to be similar to that observed between 1995 and 2002 (shown in A).
regional differences in its prevalence have been reported (7-9). Among Caucasian patients, the tendency to suffer from sIBM has been linked to the HLA-DR3 allele and the 8.1 MHC ancestral haplotype (22) . Differences in the population frequency of the HLA haplotype may be attributable to the variable prevalence of sIBM in different populations.
In Japan, an increase in the number of patients with sIBM has been recently reported (10) . This observation was obtained from a retrospective survey of Japanese patients with sIBM diagnosed at the National Center of Neurology and Psychiatry (10) . The study included 'definite' or 'probable' sIBM patients based on the criteria proposed by Needham et al. (9) . In addition to increasing recognition of sIBM as a differential diagnosis of myopathy that occurs with age, changes in dietary habits from the traditional diet to a Westernized diet after World War II, prolongation of lifespans and the transition toward sedentary lifestyles due to motorization were enumerated as the causes of the increase in the number of sIBM patients in that study (10) . Our study also demonstrated an increased number of patients with sIBM in association with age, despite an unchanged number of patients with PM or DM, findings that are consistent with those of the previous report (10) . However, the rate of increase observed in our study is not as high as that noted in the previous study. The characteristics and clinical features of the patients in our study, including sex and age at onset, are similar to those of previous large-scale studies in Western countries (23) (24) (25) (26) (27) .
As the lifespan of the Japanese population is increasing, the elderly population is increasing in size. Taking this fact into consideration, the increase in the number of patients referred to our institution may be dependent on the increasing size of the elderly population. Therefore, this study indicates that factors other than environmental background, such as the increase in the size of the elderly population, might explain the demographic movement of sIBM in Japan. Further studies are needed to confirm this finding.
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